WallStSmart

Brookfield Business Corp (BBUC)vsCresud SACIF y A (CRESY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cresud SACIF y A generates 3610% more annual revenue ($1.02T vs $27.46B). CRESY leads profitability with a 19.2% profit margin vs -0.1%. CRESY earns a higher WallStSmart Score of 75/100 (B).

BBUC

Hold

43

out of 100

Grade: D

Growth: 6.0Profit: 5.0Value: 6.7Quality: 5.0

CRESY

Strong Buy

75

out of 100

Grade: B

Growth: 8.0Profit: 7.0Value: 6.7Quality: 3.5
Piotroski: 3/9Altman Z: 0.83
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BBUCUndervalued (+88.8%)

Margin of Safety

+88.8%

Fair Value

$324.96

Current Price

$33.39

$291.57 discount

UndervaluedFair: $324.96Overvalued

Intrinsic value data unavailable for CRESY.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BBUC0 strengths · Avg: 0/10

No standout strengths identified

CRESY6 strengths · Avg: 9.2/10
P/E RatioValuation
5.1x10/10

Attractively priced relative to earnings

Price/BookValuation
0.9x10/10

Reasonable price relative to book value

EPS GrowthGrowth
182.3%10/10

Earnings expanding 182.3% YoY

Return on EquityProfitability
21.0%9/10

Every $100 of equity generates 21 in profit

Operating MarginProfitability
24.3%8/10

Strong operational efficiency at 24.3%

Revenue GrowthGrowth
20.3%8/10

Revenue surging 20.3% year-over-year

Areas to Watch

BBUC3 concerns · Avg: 2.0/10
Return on EquityProfitability
2.4%3/10

ROE of 2.4% — below average capital efficiency

Revenue GrowthGrowth
-4.5%2/10

Revenue declined 4.5%

Profit MarginProfitability
-0.1%1/10

Currently unprofitable

CRESY4 concerns · Avg: 2.8/10
Market CapQuality
$781.86M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.963/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Free Cash FlowQuality
$-26.17B2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : BBUC

BBUC has a balanced fundamental profile.

Bull Case : CRESY

The strongest argument for CRESY centers on P/E Ratio, Price/Book, EPS Growth. Profitability is solid with margins at 19.2% and operating margin at 24.3%. Revenue growth of 20.3% demonstrates continued momentum.

Bear Case : BBUC

The primary concerns for BBUC are Return on Equity, Revenue Growth, Profit Margin.

Bear Case : CRESY

The primary concerns for CRESY are Market Cap, Debt/Equity, Piotroski F-Score. Debt-to-equity of 1.96 is elevated, increasing financial risk.

Key Dynamics to Monitor

BBUC profiles as a turnaround stock while CRESY is a growth play — different risk/reward profiles.

BBUC carries more volatility with a beta of 1.38 — expect wider price swings.

CRESY is growing revenue faster at 20.3% — sustainability is the question.

BBUC generates stronger free cash flow (78M), providing more financial flexibility.

Bottom Line

CRESY scores higher overall (75/100 vs 43/100), backed by strong 19.2% margins and 20.3% revenue growth. BBUC offers better value entry with a 88.8% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Brookfield Business Corp

INDUSTRIALS · CONGLOMERATES · USA

Brookfield Business Corporation focuses on healthcare, construction and wastewater services in the United States, Europe, Australia, the United Kingdom, Canada and Brazil. The company is headquartered in New York, New York.

Cresud SACIF y A

INDUSTRIALS · CONGLOMERATES · USA

Cresud Sociedad Annima Comercial, Inmobiliaria, Financiera y Agropecuaria, an agricultural company, produces agricultural commodities in Brazil and other Latin American countries. The company is headquartered in Buenos Aires, Argentina.

Visit Website →

Want to dig deeper into these stocks?